Triclosan-loaded tooth-binding micelles for prevention and treatment of dental biofilm

Pharmaceutical Research

Volumn 27, Issue 11, 2010, Pages 2356-2364

  Chen, Fu ^a   Rice, Kelly C ^d   Liu, Xin Ming ^a   Reinhardt, Richard A ^b   Bayles, Kenneth W ^c   Wang, Dong ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

antimicrobial; biofilm; dental caries; micelle; pluronic; tooth binding; triclosan

Indexed keywords

ALENDRONIC ACID; HYDROXYAPATITE; POLOXAMER; TRICLOSAN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BIOFILM; CONTROLLED STUDY; DENTAL CARIES; DRUG BINDING; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; MICELLIZATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; STREPTOCOCCUS MUTANS;

BIOFILMS; HUMANS; MICELLES; SOLUBILITY; TRICLOSAN;

EID: 78549284872     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0119-5     Document Type: Article

References (34)

1. D Senadheera DG Cvitkovitch 2008 Quorum sensing and biofilm formation by Streptococcus mutans Adv Exp Med Biol 631 178 88 10.1007/978-0-387-78885-2-12 18792689
2. PH Keyes 1960 The infectious and transmissible nature of experimental dental caries. Findings and implications Arch Oral Biol 1 304 20 1:STN:280:DyaF3c7mtFeksQ%3D%3D 10.1016/0003-9969(60)90091-1 14408737
3. WJ Loesche 1986 Role of Streptococcus mutans in human dental decay Microbiol Rev 50 353 80 1:CAS:528:DyaL2sXmsFSrtg%3D%3D 3540569
4. HK Kuramitsu 1993 Virulence factors of mutans streptococci: role of molecular genetics Crit Rev Oral Biol Med 4 159 76 1:STN:280: DyaK3s7mvVyhsQ%3D%3D 8435464
5. HK Kuramitsu 2001 Virulence properties of oral bacteria: impact of molecular biology Curr Issues Mol Biol 3 35 6 1:CAS:528:DC%2BD3MXjvVaktbg%3D 11471973
6. GH Bowden IR Hamilton 1998 Survival of oral bacteria Crit Rev Oral Biol Med 9 54 85 1:STN:280:DyaK1c7kslGksA%3D%3D 10.1177/10454411980090010401 9488248
7. PD Marsh DJ Bradshaw 1995 Dental plaque as a biofilm J Ind Microbiol 15 169 75 1:CAS:528:DyaK2MXovVKmt7c%3D 10.1007/BF01569822 8519474
8. P Gilbert J Das I Foley 1997 Biofilm susceptibility to antimicrobials Adv Dent Res 11 160 7 1:STN:280:DyaK1c7osFWgug%3D%3D 10.1177/08959374970110010701 9524452
9. H Ceri ME Olson C Stremick RR Read D Morck A Buret 1999 The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms J Clin Microbiol 37 1771 6 1:CAS:528:DyaK1MXjslSrtLg%3D 10325322
10. F van der Ouderaaand D Cummins 1989 Delivery systems for agents in supra- and sub-gingival plaque control J Dent Res 68 1617 24
11. TE Furiaand AG Schenkel 1968 A new, broad spectrum bacteriostat Soap Chem Spec 44 47 50 116-22
12. Food and Drug Administration, FDA approves first toothpaste for gum disease, FDA Talk paper, July 14th (1997). FDA Talk paper.
13. SL Raghavan K Schuessel A Davis J Hadgraft 2003 Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems Int J Pharm 261 153 8 1:CAS:528:DC%2BD3sXls1SqsL8%3D 10.1016/S0378-5173(03) 00299-0 12878404 (Pubitemid 36962753)
14. RJ Gilbert PE Williams 1987 The oral retention and antiplaque efficacy of triclosan in human volunteers Br J Clin Pharmacol 23 579 83 1:CAS:528:DyaL2sXksVKjtr8%3D 3593627
15. TN Phan RE Marquis 2006 Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms Can J Microbiol 52 977 83 1:CAS:528:DC%2BD28XhtlejsbnF 10.1139/W06-055 17110966 (Pubitemid 46144327)
16. DJ Bradshaw PD Marsh GK Watson D Cummins 1993 The effects of triclosan and zinc citrate, alone and in combination, on a community of oral bacteria grown in vitro J Dent Res 72 25 30 1:CAS:528:DyaK3sXhs1Sls7k%3D 8380287
17. F Chen XM Liu KC Rice X Li F Yu RA Reinhardt KW Bayles D Wang 2009 Tooth-binding micelles for dental caries prevention Antimicrob Agents Chemother 53 4898 902 1:CAS:528:DC%2BD1MXhtl2itb7N 10.1128/AAC.00387-09 19704121
18. HH Murchison JF Barrett GA Cardineau R Curtiss 3rd 1986 Transformation of Streptococcus mutans with chromosomal and shuttle plasmid (pYA629) DNAs Infect Immun 54 273 82 1:CAS:528:DyaL28XmtF2qs7s%3D 3021626
19. I Biswas L Drake S Biswas 2007 Regulation of gbpC expression in Streptococcus mutans J Bacteriol 189 6521 31 1:CAS:528:DC%2BD2sXhtVKlsrjP 10.1128/JB.00825-07 17616585 (Pubitemid 47397357)
20. BD Jett KL Hatter MM Huycke MS Gilmore 1997 Simplified agar plate method for quantifying viable bacteria Biotechniques 23 648 50 1:CAS:528: DyaK2sXmslWms7Y%3D 9343684
21. Z Wei J Hao S Yuan Y Li W Juan X Sha X Fang 2009 Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization Int J Pharm 376 176 85 1:CAS:528:DC%2BD1MXntFyntrY%3D 10.1016/j.ijpharm.2009.04.030 19409463
22. E Blanco EA Bey Y Dong BD Weinberg DM Sutton DA Boothman J Gao 2007 Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells J Control Release 122 365 74 1:CAS:528:DC%2BD2sXhtVKrsLrJ 10.1016/j.jconrel.2007.04.014 17574288 (Pubitemid 47404665)
23. DA Chiappetta J Degrossi S Teves M D'Aquino C Bregni A Sosnik 2008 Triclosan-loaded poloxamine micelles for enhanced topical antibacterial activity against biofilm Eur J Pharm Biopharm 69 535 45 1:CAS:528:DC%2BD1cXmtVSgsro%3D 10.1016/j.ejpb.2007.11.021 18194853
24. H Shinoda G Adamek R Felix H Fleisch R Schenk P Hagan 1983 Structure-activity relationships of various bisphosphonates Calcif Tissue Int 35 87 99 1:CAS:528:DyaL3sXhslamtbk%3D 10.1007/BF02405012 6839194
25. R Fujisawa Y Wada Y Nodasaka Y Kuboki 1996 Acidic amino acid-rich sequences as binding sites of osteonectin to hydroxyapatite crystals Biochim Biophys Acta 1292 53 60 8547349
26. L Yang X Wu F Liu Y Duan S Li 2009 Novel biodegradable polylactide/poly(ethylene glycol) micelles prepared by direct dissolution method for controlled delivery of anticancer drugs Pharm Res 26 2332 42 1:CAS:528:DC%2BD1MXpsF2it7Y%3D 10.1007/s11095-009-9949-4 19669098
27. KT Oh TK Bronich AV Kabanov 2004 Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic block copolymers J Control Release 94 411 22 1:CAS:528:DC%2BD2cXmtFCqtA%3D%3D 10.1016/j.jconrel. 2003.10.018 14744491 (Pubitemid 38117151)
28. R. Nagarajan. Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic® (PEO-PPO-PEO) block copolymers. Coll. Surf. B: Biointerf. 1999; 55-72.
29. RL Xu MA Winnik FR Hallett G Riess MD Croucher 1991 Light-scattering study of the association behavior of styrene-ethylene oxide block copolymers in aqueous solution Macromolecules 24 87 93 1:CAS:528:DyaK3MXisFSmsQ%3D%3D 10.1021/ma00001a014
30. Chu B, Zhou Z. Nonionic Surfactants: polyoxyalkylene block copolymers. New York: Marcel Dekker, Inc.; 1996.
31. AV Kabanov VY Alakhov 2002 Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers Crit Rev Ther Drug Carrier Syst 19 1 72 1:CAS:528:DC%2BD38XksFaltLw%3D 10.1615/ CritRevTherDrugCarrierSyst.v19.i1.10 12046891 (Pubitemid 34521248)
32. SR Croy GS Kwon 2006 Polymeric micelles for drug delivery Curr Pharm Des 12 4669 84 1:CAS:528:DC%2BD2sXmsFCnsw%3D%3D 10.2174/138161206779026245 17168771 (Pubitemid 44835136)
33. MY Kozlov NS Melik-Nubarov EV Batrakova AV Kabanov 2000 Relationship between Pluronic Block Copolymer Structure. Critical Micellization Concentration and Partitioning Coefficients of Low Molecular Mass Solutes Macromolecules 33 3305 13 1:CAS:528:DC%2BD3cXitF2gt7g%3D 10.1021/ma991634x
34. K Sjogren AB Lundberg D Birkhed DJ Dudgeon MR Johnson 2004 Interproximal plaque mass and fluoride retention after brushing and flossing-a comparative study of powered toothbrushing, manual toothbrushing and flossing Oral Health Prev Dent 2 119 24 15646945